← 返回前沿论文

罕见的 Rosai-Dorfman 病伴严重淋巴细胞减少症的表现:一例儿科病例报告及文献综述

英文原题:Rare presentation of Rosai-Dorfman disease with severe lymphopenia: a pediatric case report and review of the literature.

查看英文原题

Rare presentation of Rosai-Dorfman disease with severe lymphopenia: a pediatric case report and review of the literature.

PubMed 2026/05/11(内容时间) J Cancer Res Clin Oncol Q2 · IF 3.3(JCR 2025)

研究概要

本病例扩展了RDD的免疫学谱系,并突出表现为孤立性严重淋巴细胞减少这一独特罕见的临床表现。

中文摘要

Rosai-Dorfman病(RDD)是一种罕见的组织细胞增生症,通常表现为无痛性双侧颈部淋巴结肿大和白细胞增多。血细胞减少,尤其是孤立性淋巴细胞减少,尤为罕见且特征不明确。在此,我们报告一例3岁男童,表现为进行性双侧颈部淋巴结肿大和严重的T细胞及B细胞淋巴细胞减少。免疫表型分析显示CD3+、CD4+、CD8+和CD19+细胞显著减少,NK细胞处于低临界水平,TCRγδ+双阴性(CD3+/CD4-/CD8-)T细胞扩增。B细胞亚群分析显示转换记忆B细胞和边缘区B细胞区室减少,过渡性B细胞增多,提示免疫失调。影像学证实广泛的颈部和纵隔淋巴结肿大。淋巴结切除活检显示特征性的窦组织细胞增生伴伸入运动,确诊为淋巴结RDD。未检测到自身抗体,骨髓检查和基因检测无异常。鉴于临床稳定且无器官功能障碍,患者接受预防性抗微生物药物和密切监测的保守治疗,随访期间保持稳定。我们还进行了文献综述,确定了8例特征明确的RDD伴血细胞减少病例,其中仅2例报告了孤立性淋巴细胞减少,强调了该表现的罕见性。大多数病例因自身免疫特征或疾病进展需要全身性免疫抑制治疗。详细的淋巴细胞亚群特征分析鲜有报道。总之,本病例扩展了RDD的免疫学谱系,并突出孤立性严重淋巴细胞减少作为一种独特罕见的表现。综合免疫分型对于区分RDD与原发性免疫缺陷及淋巴增殖性疾病至关重要,因为免疫失调型RDD可能代表一个生物学上独特的亚组,对精准管理具有重要意义。

展开英文摘要原文

Rosai-Dorfman disease (RDD) is a rare type of histiocytosis usually presenting with painless bilateral cervical lymphadenopathy and leukocytosis. Cytopenias, particularly isolated lymphopenia, are particularly uncommon and poorly characterized. Hereby, we report a case of a 3-year-old boy presenting with progressive bilateral cervical lymphadenopathy and profound T- and B-cell lymphopenia. Immunophenotyping demonstrated markedly reduced CD3 + , CD4 + , CD8 + , and CD19 + cells, low borderline level of NK-cells, and expansion of TCRγδ + double-negative (CD3 + /CD4 - /CD8 - ) T cells. B-cell subset analysis revealed reduced switched memory and marginal zone compartments with increased transitional B cells, suggesting immune dysregulation. Imaging confirmed extensive cervical and mediastinal lymphadenopathy. Lymph node excision biopsy showed characteristic sinus histiocytosis with emperipolesis, confirming the diagnosis of nodal RDD. No autoantibodies were detected, and bone marrow examination and genetic testing were unremarkable. Given the clinical stability and absence of organ dysfunction, the patient was conservatively managed with prophylactic antimicrobials and close surveillance, remaining stable at follow-up. A review of the literature was also conducted, identifying eight well-characterized RDD cases associated with cytopenia, involving only two cases reporting isolated lymphopenia, emphasizing the rarity of this presentation. Most cases required systemic immunosuppression due to autoimmune features or progressive disease. Detailed lymphocyte subset characterization was rarely reported. In conclusion, this case expands the immunologic spectrum of RDD and highlights isolated severe lymphopenia as a uniquely rare presentation. Comprehensive immunophenotyping is essential to distinguish RDD from primary immunodeficiency and lymphoproliferative disorders, as immune-dysregulated RDD may represent a biologically distinct subgroup with implications for precision management.

论文信息

作者
Abdalla D、Radcliffe R、Asfour H
第一作者单位
Department of Paediatric Oncology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK.United Kingdom
通讯作者单位
Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, Clinical Sciences BuildingLeicester Royal Infirmary, Leicester, LE1 5WW, UK. ha364@le.ac.uk.United Kingdom
文献类型
病例报告 · 综述
期刊
Journal of cancer research and clinical oncology2026 May 11
原文标识
PubMed 42113276 · DOI 10.1007/s00432-026-06496-8